Disease onset forecasting on Patient EHR dataset Pancreatic Cancer 2-year horizon (test)
0.693AUROCRAVEN
Evaluation results
| Method | Links | ||
|---|---|---|---|
| RAVENEvaluation protocol=Zero-shot, Inference method=Single forward pass2026.03 | 0.693 | 0.002 | |
| BERT (FT)Evaluation protocol=Supervised (Fine-tuned)2026.03 | 0.6 | 0.001 | |
| EGEEvaluation protocol=Zero-shot, Inference method=Monte Carlo rollouts (R=100)2026.03 | 0.501 | 0.0005 | |
| MulticlassEvaluation protocol=Zero-shot, Inference method=Monte Carlo rollouts (R=100)2026.03 | 0.496 | 0.0002 | |
| SeqLossEvaluation protocol=Zero-shot, Inference method=Monte Carlo rollouts (R=100)2026.03 | 0.494 | 0.001 |